Runben Biotechnology Co., Ltd. (SHA:603193)

China · Delayed Price · Currency is CNY

17.10

-0.23 (-1.33%)

Oct 29, 2026, 2:54 PM CST

Market Cap	6.92B -35.5%
Revenue (ttm)	1.71B +12.9%
Net Income	348.54M +14.2%
EPS	0.86 +13.4%
Shares Out	404.59M
PE Ratio	19.87
Forward PE	18.74
Dividend	0.54 (3.16%)
Ex-Dividend Date	Sep 21, 2026

Volume	1,932,096
Open	17.36
Previous Close	17.33
Day's Range	16.96 - 17.37
52-Week Range	17.01 - 26.78
Beta	0.18
Analysts	Strong Buy
Price Target	29.85 (+74.56%)
Earnings Date	Oct 20, 2026

About Runben Biotechnology

Runben Biotechnology Co., Ltd. engages in the research, production, and sale of mosquito repellent products, infant care products, and essential oil products. The company also sells its products through online channels. Runben Biotechnology Co., Ltd. was founded in 1993 and is based in Guangzhou, China. [Read more]

Industry Household & Personal Products

Sector Consumer Staples

Founded 1993

Employees 1,018

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603193

Full Company Profile

Financial Performance

In 2025, Runben Biotechnology's revenue was 1.54 billion, an increase of 17.19% compared to the previous year's 1.32 billion. Earnings were 314.50 million, an increase of 4.78%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 603193 stock is "Strong Buy." The 12-month stock price target is ¥29.85, which is an increase of 74.56% from the latest price.

Price Target

¥29.85

(74.56% upside)

Analyst Consensus: Strong Buy

Stock Forecasts